Research Article
Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East
Table 3
Multivariate logistic regression results assess the risk factors associated with in-hospital mortality among inpatients with confirmed COVID-19.
| Covariate | Univariate regression | Multivariate regression | Or (95% CI) | value | Or (95% CI) | value |
| Age, years | | | | | 18–40 (reference) | | | | | 41–65 | 1.45 (0.96–2.21) | 0.079 | 1.06 (0.68–1.67) | 0.786 | >65 | 3.39 (2.24–5.13) | <0.001 | 2.01 (1.28–3.16) | 0.003 |
| Severity | | | | | Moderate (reference) | | | | | Severe | 1.48 (1.04–2.12) | 0.032 | 1.56 (1.05–2.32) | <0.001 | Critical | 2.72 (1.94–3.80) | <0.001 | 2.94 (2.02–4.27) | <0.001 |
| Smoking status | | | | | Nonsmoker (reference) | | | | | Current smoker | 1.48 (1.11–1.98) | 0.008 | 1.61 (1.17–2.23) | 0.004 | Ex-smoker | 1.43 (1.05–1.95) | 0.024 | 1.31 (0.94–1.84) | 0.115 |
| Comorbidities | | | | | Chronic kidney disease, yes vs. no | 3.72 (2.53–5.46) | <0.001 | 2.90 (1.90–4.43) | <0.001 | Diabetes miletus, yes vs. no | 1.41 (1.15–1.72) | 0.001 | 1.31 (1.04–1.65) | 0.022 | Heart failure, yes vs. no | 1.82 (1.29–2.57) | 0.001 | 1.51 (1.02–2.23) | 0.041 | History of DVT/PE, yes vs. no | 2.28 (1.04–5.00) | 0.040 | 2.62 (1.08–6.35) | 0.033 | Malignancy, yes vs. no | 2.10 (1.44–3.06) | <0.001 | 2.221 (1.46–3.38) | <0.001 |
| Lab results | | | | | Sodium normal (reference) | | | | | Hypernatremia | 14.71 (5.77–37.52) | <0.001 | 11.37 (4.33–29.81) | <0.001 | Hyponatremia | 1.11 (0.88–1.40) | 0.374 | 0.91 (0.71–1.18) | 0.474 | Albumin normal (reference) | | | | | Hypoalbuminemia | 2.47 (1.97–3.10) | <0.001 | 1.75 (1.37–2.25) | <0.001 | Normal AST level (reference) | | | | | High AST level | 1.80 (1.45–2.24) | <0.001 | 1.81 (1.42–2.31) | <0.001 | Platelets normal (reference) | | | | | Platelets high | 0.88 (0.61–1.28) | 0.499 | 0.84 (0.56–1.27) | 0.402 | Platelets low | 1.52 (1.15–2.00) | 0.003 | 1.43 (1.05–1.95) | 0.024 |
|
|